APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cholesterol Lowering Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cholesterol Lowering Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchCholesterol Lowering Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Cholesterol Lowering Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Cholesterol Lowering Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cholesterol Lowering Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Cholesterol Lowering Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Cholesterol Lowering Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cholesterol Lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cholesterol Lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cholesterol Lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cholesterol Lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cholesterol Lowering Drugs include Innovent Biologics, Sanofi, Novartis, Merck, Akeso, Pfizer, Hisun Pharmaceutical, Zydus and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cholesterol Lowering Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cholesterol Lowering Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cholesterol Lowering Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cholesterol Lowering Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Cholesterol Lowering Drugs Segment by Company

Innovent Biologics

Sanofi

Novartis

Merck

Akeso

Pfizer

Hisun Pharmaceutical

Zydus

Viatris

Teva

Regeneron Pharmaceuticals

Otsuka Pharmaceutical

Medicure Pharma

Kowa Pharmaceuticals

Glenmark

Esperion Therapeutics

Cosette Pharmaceuticals

Cheplapharm Arzneimittel

Apotex

Amgen

Cholesterol Lowering Drugs Segment by Type

PCSK9 Inhibitors

Cholesterol Chelators

Cholesterol Absorption Inhibitors

Statins

Others

Cholesterol Lowering Drugs Segment by Application

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Cholesterol Lowering Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholesterol Lowering Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cholesterol Lowering Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholesterol Lowering Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cholesterol Lowering Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cholesterol Lowering Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cholesterol Lowering Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cholesterol Lowering Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cholesterol Lowering Drugs Industry Trends Table 2. Cholesterol Lowering Drugs Industry Drivers Table 3. Cholesterol Lowering Drugs Industry Opportunities and Challenges Table 4. Cholesterol Lowering Drugs Industry Restraints Table 5. Global Cholesterol Lowering Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cholesterol Lowering Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cholesterol Lowering Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cholesterol Lowering Drugs Sales Market Share by Manufacturers Table 9. Global Cholesterol Lowering Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cholesterol Lowering Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cholesterol Lowering Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cholesterol Lowering Drugs Manufacturers, Product Type & Application Table 13. Global Cholesterol Lowering Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cholesterol Lowering Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PCSK9 Inhibitors Table 17. Major Manufacturers of Cholesterol Chelators Table 18. Major Manufacturers of Cholesterol Absorption Inhibitors Table 19. Major Manufacturers of Statins Table 20. Major Manufacturers of Others Table 21. Global Cholesterol Lowering Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Cholesterol Lowering Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Cholesterol Lowering Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Cholesterol Lowering Drugs Sales Market Share by Type (2021-2026) Table 25. Global Cholesterol Lowering Drugs Sales Market Share by Type (2027-2032) Table 26. Global Cholesterol Lowering Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Cholesterol Lowering Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Cholesterol Lowering Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Cholesterol Lowering Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Cholesterol Lowering Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Pharmacy Table 32. Major Manufacturers of Retail Pharmacy Table 33. Major Manufacturers of Online Pharmacy Table 34. Global Cholesterol Lowering Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Cholesterol Lowering Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Cholesterol Lowering Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Cholesterol Lowering Drugs Sales Market Share by Application (2021-2026) Table 38. Global Cholesterol Lowering Drugs Sales Market Share by Application (2027-2032) Table 39. Global Cholesterol Lowering Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Cholesterol Lowering Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Cholesterol Lowering Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Cholesterol Lowering Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Cholesterol Lowering Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Cholesterol Lowering Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Cholesterol Lowering Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Cholesterol Lowering Drugs Sales Market Share by Region (2021-2026) Table 47. Global Cholesterol Lowering Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Cholesterol Lowering Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Cholesterol Lowering Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Cholesterol Lowering Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Cholesterol Lowering Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Cholesterol Lowering Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Cholesterol Lowering Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Cholesterol Lowering Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Cholesterol Lowering Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Cholesterol Lowering Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Cholesterol Lowering Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Cholesterol Lowering Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Cholesterol Lowering Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Cholesterol Lowering Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Cholesterol Lowering Drugs Revenue Market Share by Region (2027-2032) Table 66. Innovent Biologics Company Information Table 67. Innovent Biologics Business Overview Table 68. Innovent Biologics Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Innovent Biologics Cholesterol Lowering Drugs Product Portfolio Table 70. Innovent Biologics Recent Development Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sanofi Cholesterol Lowering Drugs Product Portfolio Table 75. Sanofi Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Novartis Cholesterol Lowering Drugs Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merck Cholesterol Lowering Drugs Product Portfolio Table 85. Merck Recent Development Table 86. Akeso Company Information Table 87. Akeso Business Overview Table 88. Akeso Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Akeso Cholesterol Lowering Drugs Product Portfolio Table 90. Akeso Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Pfizer Cholesterol Lowering Drugs Product Portfolio Table 95. Pfizer Recent Development Table 96. Hisun Pharmaceutical Company Information Table 97. Hisun Pharmaceutical Business Overview Table 98. Hisun Pharmaceutical Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Hisun Pharmaceutical Cholesterol Lowering Drugs Product Portfolio Table 100. Hisun Pharmaceutical Recent Development Table 101. Zydus Company Information Table 102. Zydus Business Overview Table 103. Zydus Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Zydus Cholesterol Lowering Drugs Product Portfolio Table 105. Zydus Recent Development Table 106. Viatris Company Information Table 107. Viatris Business Overview Table 108. Viatris Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Viatris Cholesterol Lowering Drugs Product Portfolio Table 110. Viatris Recent Development Table 111. Teva Company Information Table 112. Teva Business Overview Table 113. Teva Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Teva Cholesterol Lowering Drugs Product Portfolio Table 115. Teva Recent Development Table 116. Regeneron Pharmaceuticals Company Information Table 117. Regeneron Pharmaceuticals Business Overview Table 118. Regeneron Pharmaceuticals Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Regeneron Pharmaceuticals Cholesterol Lowering Drugs Product Portfolio Table 120. Regeneron Pharmaceuticals Recent Development Table 121. Otsuka Pharmaceutical Company Information Table 122. Otsuka Pharmaceutical Business Overview Table 123. Otsuka Pharmaceutical Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Otsuka Pharmaceutical Cholesterol Lowering Drugs Product Portfolio Table 125. Otsuka Pharmaceutical Recent Development Table 126. Medicure Pharma Company Information Table 127. Medicure Pharma Business Overview Table 128. Medicure Pharma Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Medicure Pharma Cholesterol Lowering Drugs Product Portfolio Table 130. Medicure Pharma Recent Development Table 131. Kowa Pharmaceuticals Company Information Table 132. Kowa Pharmaceuticals Business Overview Table 133. Kowa Pharmaceuticals Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Kowa Pharmaceuticals Cholesterol Lowering Drugs Product Portfolio Table 135. Kowa Pharmaceuticals Recent Development Table 136. Glenmark Company Information Table 137. Glenmark Business Overview Table 138. Glenmark Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Glenmark Cholesterol Lowering Drugs Product Portfolio Table 140. Glenmark Recent Development Table 141. Esperion Therapeutics Company Information Table 142. Esperion Therapeutics Business Overview Table 143. Esperion Therapeutics Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Esperion Therapeutics Cholesterol Lowering Drugs Product Portfolio Table 145. Esperion Therapeutics Recent Development Table 146. Cosette Pharmaceuticals Company Information Table 147. Cosette Pharmaceuticals Business Overview Table 148. Cosette Pharmaceuticals Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Cosette Pharmaceuticals Cholesterol Lowering Drugs Product Portfolio Table 150. Cosette Pharmaceuticals Recent Development Table 151. Cheplapharm Arzneimittel Company Information Table 152. Cheplapharm Arzneimittel Business Overview Table 153. Cheplapharm Arzneimittel Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Cheplapharm Arzneimittel Cholesterol Lowering Drugs Product Portfolio Table 155. Cheplapharm Arzneimittel Recent Development Table 156. Apotex Company Information Table 157. Apotex Business Overview Table 158. Apotex Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Apotex Cholesterol Lowering Drugs Product Portfolio Table 160. Apotex Recent Development Table 161. Amgen Company Information Table 162. Amgen Business Overview Table 163. Amgen Cholesterol Lowering Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Amgen Cholesterol Lowering Drugs Product Portfolio Table 165. Amgen Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Cholesterol Lowering Drugs Distributors List Table 169. Cholesterol Lowering Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Cholesterol Lowering Drugs Product Image Figure 2. Global Cholesterol Lowering Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cholesterol Lowering Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Cholesterol Lowering Drugs Sales (2021-2032) & (K Units) Figure 5. Global Cholesterol Lowering Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cholesterol Lowering Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PCSK9 Inhibitors Image Figure 9. Cholesterol Chelators Image Figure 10. Cholesterol Absorption Inhibitors Image Figure 11. Statins Image Figure 12. Others Image Figure 13. Global Cholesterol Lowering Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cholesterol Lowering Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cholesterol Lowering Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Cholesterol Lowering Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Cholesterol Lowering Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Cholesterol Lowering Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospital Pharmacy Image Figure 20. Retail Pharmacy Image Figure 21. Online Pharmacy Image Figure 22. Global Cholesterol Lowering Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cholesterol Lowering Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cholesterol Lowering Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Cholesterol Lowering Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Cholesterol Lowering Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Cholesterol Lowering Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Cholesterol Lowering Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Cholesterol Lowering Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Cholesterol Lowering Drugs Sales Market Share by Country (2021-2032) Figure 42. China Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Cholesterol Lowering Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Cholesterol Lowering Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Cholesterol Lowering Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Cholesterol Lowering Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Cholesterol Lowering Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Cholesterol Lowering Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Cholesterol Lowering Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Cholesterol Lowering Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Cholesterol Lowering Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Cholesterol Lowering Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • PCSK9 Inhibitors
  • Cholesterol Chelators
  • Cholesterol Absorption Inhibitors
  • Statins
  • Others
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Companies covered
  • Innovent Biologics
  • Sanofi
  • Novartis
  • Merck
  • Akeso
  • Pfizer
  • Hisun Pharmaceutical
  • Zydus
  • Viatris
  • Teva
  • Regeneron Pharmaceuticals
  • Otsuka Pharmaceutical
  • Medicure Pharma
  • Kowa Pharmaceuticals
  • Glenmark
  • Esperion Therapeutics
  • Cosette Pharmaceuticals
  • Cheplapharm Arzneimittel
  • Apotex
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cholesterol Lowering Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cholesterol Lowering Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cholesterol Lowering Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cholesterol Lowering Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cholesterol Lowering Drugs Market Dynamics
  1. 2.1 Cholesterol Lowering Drugs Industry Trends
  2. 2.2 Cholesterol Lowering Drugs Industry Drivers
  3. 2.3 Cholesterol Lowering Drugs Industry Opportunities and Challenges
  4. 2.4 Cholesterol Lowering Drugs Industry Restraints
3 Cholesterol Lowering Drugs Market by Manufacturers
  1. 3.1 Global Cholesterol Lowering Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cholesterol Lowering Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cholesterol Lowering Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cholesterol Lowering Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cholesterol Lowering Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cholesterol Lowering Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Cholesterol Lowering Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cholesterol Lowering Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cholesterol Lowering Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cholesterol Lowering Drugs Tier 1, Tier 2, and Tier 3
4 Cholesterol Lowering Drugs Market by Type
  1. 4.1 Cholesterol Lowering Drugs Type Introduction
  2. 4.1.1 PCSK9 Inhibitors
  3. 4.1.2 Cholesterol Chelators
  4. 4.1.3 Cholesterol Absorption Inhibitors
  5. 4.1.4 Statins
  6. 4.1.5 Others
  7. 4.2 Global Cholesterol Lowering Drugs Sales by Type
  8. 4.2.1 Global Cholesterol Lowering Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Cholesterol Lowering Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Cholesterol Lowering Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Cholesterol Lowering Drugs Revenue by Type
  12. 4.3.1 Global Cholesterol Lowering Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Cholesterol Lowering Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Cholesterol Lowering Drugs Revenue Market Share by Type (2021-2032)
5 Cholesterol Lowering Drugs Market by Application
  1. 5.1 Cholesterol Lowering Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Cholesterol Lowering Drugs Sales by Application
  6. 5.2.1 Global Cholesterol Lowering Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cholesterol Lowering Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Cholesterol Lowering Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cholesterol Lowering Drugs Revenue by Application
  10. 5.3.1 Global Cholesterol Lowering Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cholesterol Lowering Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Cholesterol Lowering Drugs Revenue Market Share by Application (2021-2032)
6 Global Cholesterol Lowering Drugs Sales by Region
  1. 6.1 Global Cholesterol Lowering Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cholesterol Lowering Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Cholesterol Lowering Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Cholesterol Lowering Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cholesterol Lowering Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cholesterol Lowering Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cholesterol Lowering Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cholesterol Lowering Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cholesterol Lowering Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cholesterol Lowering Drugs Revenue by Region
  1. 7.1 Global Cholesterol Lowering Drugs Revenue by Region
  2. 7.1.1 Global Cholesterol Lowering Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cholesterol Lowering Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Cholesterol Lowering Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Cholesterol Lowering Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cholesterol Lowering Drugs Revenue (2021-2032)
  8. 7.2.2 North America Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cholesterol Lowering Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cholesterol Lowering Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cholesterol Lowering Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cholesterol Lowering Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Innovent Biologics
  2. 8.1.1 Innovent Biologics Company Information
  3. 8.1.2 Innovent Biologics Business Overview
  4. 8.1.3 Innovent Biologics Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Innovent Biologics Cholesterol Lowering Drugs Product Portfolio
  6. 8.1.5 Innovent Biologics Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Cholesterol Lowering Drugs Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Cholesterol Lowering Drugs Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Cholesterol Lowering Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Akeso
  26. 8.5.1 Akeso Company Information
  27. 8.5.2 Akeso Business Overview
  28. 8.5.3 Akeso Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Akeso Cholesterol Lowering Drugs Product Portfolio
  30. 8.5.5 Akeso Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Cholesterol Lowering Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Hisun Pharmaceutical
  38. 8.7.1 Hisun Pharmaceutical Company Information
  39. 8.7.2 Hisun Pharmaceutical Business Overview
  40. 8.7.3 Hisun Pharmaceutical Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hisun Pharmaceutical Cholesterol Lowering Drugs Product Portfolio
  42. 8.7.5 Hisun Pharmaceutical Recent Developments
  43. 8.8 Zydus
  44. 8.8.1 Zydus Company Information
  45. 8.8.2 Zydus Business Overview
  46. 8.8.3 Zydus Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Cholesterol Lowering Drugs Product Portfolio
  48. 8.8.5 Zydus Recent Developments
  49. 8.9 Viatris
  50. 8.9.1 Viatris Company Information
  51. 8.9.2 Viatris Business Overview
  52. 8.9.3 Viatris Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Viatris Cholesterol Lowering Drugs Product Portfolio
  54. 8.9.5 Viatris Recent Developments
  55. 8.10 Teva
  56. 8.10.1 Teva Company Information
  57. 8.10.2 Teva Business Overview
  58. 8.10.3 Teva Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Cholesterol Lowering Drugs Product Portfolio
  60. 8.10.5 Teva Recent Developments
  61. 8.11 Regeneron Pharmaceuticals
  62. 8.11.1 Regeneron Pharmaceuticals Company Information
  63. 8.11.2 Regeneron Pharmaceuticals Business Overview
  64. 8.11.3 Regeneron Pharmaceuticals Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Regeneron Pharmaceuticals Cholesterol Lowering Drugs Product Portfolio
  66. 8.11.5 Regeneron Pharmaceuticals Recent Developments
  67. 8.12 Otsuka Pharmaceutical
  68. 8.12.1 Otsuka Pharmaceutical Company Information
  69. 8.12.2 Otsuka Pharmaceutical Business Overview
  70. 8.12.3 Otsuka Pharmaceutical Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Otsuka Pharmaceutical Cholesterol Lowering Drugs Product Portfolio
  72. 8.12.5 Otsuka Pharmaceutical Recent Developments
  73. 8.13 Medicure Pharma
  74. 8.13.1 Medicure Pharma Company Information
  75. 8.13.2 Medicure Pharma Business Overview
  76. 8.13.3 Medicure Pharma Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medicure Pharma Cholesterol Lowering Drugs Product Portfolio
  78. 8.13.5 Medicure Pharma Recent Developments
  79. 8.14 Kowa Pharmaceuticals
  80. 8.14.1 Kowa Pharmaceuticals Company Information
  81. 8.14.2 Kowa Pharmaceuticals Business Overview
  82. 8.14.3 Kowa Pharmaceuticals Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kowa Pharmaceuticals Cholesterol Lowering Drugs Product Portfolio
  84. 8.14.5 Kowa Pharmaceuticals Recent Developments
  85. 8.15 Glenmark
  86. 8.15.1 Glenmark Company Information
  87. 8.15.2 Glenmark Business Overview
  88. 8.15.3 Glenmark Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Glenmark Cholesterol Lowering Drugs Product Portfolio
  90. 8.15.5 Glenmark Recent Developments
  91. 8.16 Esperion Therapeutics
  92. 8.16.1 Esperion Therapeutics Company Information
  93. 8.16.2 Esperion Therapeutics Business Overview
  94. 8.16.3 Esperion Therapeutics Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Esperion Therapeutics Cholesterol Lowering Drugs Product Portfolio
  96. 8.16.5 Esperion Therapeutics Recent Developments
  97. 8.17 Cosette Pharmaceuticals
  98. 8.17.1 Cosette Pharmaceuticals Company Information
  99. 8.17.2 Cosette Pharmaceuticals Business Overview
  100. 8.17.3 Cosette Pharmaceuticals Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cosette Pharmaceuticals Cholesterol Lowering Drugs Product Portfolio
  102. 8.17.5 Cosette Pharmaceuticals Recent Developments
  103. 8.18 Cheplapharm Arzneimittel
  104. 8.18.1 Cheplapharm Arzneimittel Company Information
  105. 8.18.2 Cheplapharm Arzneimittel Business Overview
  106. 8.18.3 Cheplapharm Arzneimittel Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cheplapharm Arzneimittel Cholesterol Lowering Drugs Product Portfolio
  108. 8.18.5 Cheplapharm Arzneimittel Recent Developments
  109. 8.19 Apotex
  110. 8.19.1 Apotex Company Information
  111. 8.19.2 Apotex Business Overview
  112. 8.19.3 Apotex Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Apotex Cholesterol Lowering Drugs Product Portfolio
  114. 8.19.5 Apotex Recent Developments
  115. 8.20 Amgen
  116. 8.20.1 Amgen Company Information
  117. 8.20.2 Amgen Business Overview
  118. 8.20.3 Amgen Cholesterol Lowering Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Amgen Cholesterol Lowering Drugs Product Portfolio
  120. 8.20.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cholesterol Lowering Drugs Value Chain Analysis
  2. 9.1.1 Cholesterol Lowering Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cholesterol Lowering Drugs Production Mode & Process
  6. 9.2 Cholesterol Lowering Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cholesterol Lowering Drugs Distributors
  9. 9.2.3 Cholesterol Lowering Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst